Continuous Positive Airway Pressure(CPAP) Therapy Comfort

Not Applicable

Completed

• Conditions: Obstructive Sleep Apnoea; Respiratory - Sleep apnoea

• Registration Number: ACTRN12613000712707
• Lead Sponsor: Fisher & Paykel Healthcare

Brief Summary

The primary outcome of this study was to evaluate patient preference of different prototype Continuous Positive Airway Pressure (CPAP) and masks. 161 of 300 patients were trialed as we were unable to reach the anticipated number of 300 patients. However, this did not adversely affect the outcome of this study and was deemed sufficient. There were no withdrawals of patients or adverse events during the course of the study. The ethics in relation to this study has closed with reference to the following ethics number 13/NTB/63. The results of this study were primarily for internal feedback for future product development and not intended for market release.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-06-28
• Study Completion: 2015-09-21
• Last Update Posted: 10 February 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 161

Inclusion Criteria

Aged 18 years or older
Able to give informed consent

(this study will include healthy volunteers, patients that are awaiting a sleep study with a suspicion of OSA, and patients diagnosed with OSA)

Exclusion Criteria

Contraindicated for CPAP/AutoCPAP therapy
Must not require supplemental oxygen
Must not have critical medical device (i.e. cardiac pacemaker)

Study & Design

• Study Type: Interventional
• Study Design: Not specified